FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146826953> ?p ?o ?g. }

• W2146826953 endingPage "1525" @default.
• W2146826953 startingPage "1516" @default.
• W2146826953 abstract "Peroxisome proliferator-activated receptor alpha (PPARalpha) is a member of the nuclear receptor family of ligand-activated transcription factors. It plays an important role in the regulation of genes involved in lipid metabolism and transport. Compound A is a potent and orally active PPARalpha agonist that activated both human and rat PPARalpha receptors. The compound induced the expression of genes involved in fatty acid metabolism in a rodent hepatoma cell line and in the liver of db/db mouse. The ability of compound A to stimulate fatty acid beta-oxidation was demonstrated in human hepatocytes and human skeletal muscle cells, which confirmed a functional activation of PPARalpha-mediated activities. Compound A was shown to be a more potent and efficacious antidyslipidemic agent in atherogenic rat and db/db mouse models as compared with fenofibrate. The increase in high-density lipoprotein cholesterol levels by compound A was at least partially due to an increase in serum apolipoprotein A-I protein concentrations in human PPARalpha transgenic mouse. The triglyceride-lowering effect was further confirmed in a higher species, obese dog models. In addition, compound A dose-dependently ameliorated hyperglycemia and hyperinsulinemia, and improved glucose tolerance in db/db mice. In a diet-induced obesity mouse model, compound A decreased body weight mainly by increasing energy expenditure and reducing fat deposition. In conclusion, the novel and potent PPARalpha agonist improves lipid profile, insulin sensitivity, and energy balance in animal models." @default.
• W2146826953 created "2016-06-24" @default.
• W2146826953 creator A5000922713 @default.
• W2146826953 creator A5012353323 @default.
• W2146826953 creator A5026167433 @default.
• W2146826953 creator A5030740220 @default.
• W2146826953 creator A5036099832 @default.
• W2146826953 creator A5042785839 @default.
• W2146826953 creator A5053797937 @default.
• W2146826953 creator A5055742618 @default.
• W2146826953 creator A5088443332 @default.
• W2146826953 creator A5089781644 @default.
• W2146826953 date "2008-11-01" @default.
• W2146826953 modified "2023-10-16" @default.
• W2146826953 title "Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator–activated receptor α agonist" @default.
• W2146826953 cites W1485967434 @default.
• W2146826953 cites W1504497430 @default.
• W2146826953 cites W1650965741 @default.
• W2146826953 cites W1964716328 @default.
• W2146826953 cites W1969478165 @default.
• W2146826953 cites W1978039335 @default.
• W2146826953 cites W1979080082 @default.
• W2146826953 cites W1987096050 @default.
• W2146826953 cites W2007414597 @default.
• W2146826953 cites W2010556458 @default.
• W2146826953 cites W2011959411 @default.
• W2146826953 cites W2017421207 @default.
• W2146826953 cites W2034649412 @default.
• W2146826953 cites W2047559956 @default.
• W2146826953 cites W2064861744 @default.
• W2146826953 cites W2066092624 @default.
• W2146826953 cites W2066963386 @default.
• W2146826953 cites W2067096633 @default.
• W2146826953 cites W2070299412 @default.
• W2146826953 cites W2079823672 @default.
• W2146826953 cites W2089229368 @default.
• W2146826953 cites W2104875047 @default.
• W2146826953 cites W2108672863 @default.
• W2146826953 cites W2108971974 @default.
• W2146826953 cites W2112375566 @default.
• W2146826953 cites W2121914083 @default.
• W2146826953 cites W2125387769 @default.
• W2146826953 cites W2126317966 @default.
• W2146826953 cites W2134815606 @default.
• W2146826953 cites W2135985666 @default.
• W2146826953 cites W2137046761 @default.
• W2146826953 cites W2143893927 @default.
• W2146826953 cites W2187198350 @default.
• W2146826953 cites W30399182 @default.
• W2146826953 cites W3063220799 @default.
• W2146826953 cites W4205980894 @default.
• W2146826953 cites W4232051691 @default.
• W2146826953 cites W4250981874 @default.
• W2146826953 doi "https://doi.org/10.1016/j.metabol.2008.06.005" @default.
• W2146826953 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18940388" @default.
• W2146826953 hasPublicationYear "2008" @default.
• W2146826953 type Work @default.
• W2146826953 sameAs 2146826953 @default.
• W2146826953 citedByCount "26" @default.
• W2146826953 countsByYear W21468269532012 @default.
• W2146826953 countsByYear W21468269532013 @default.
• W2146826953 countsByYear W21468269532014 @default.
• W2146826953 countsByYear W21468269532015 @default.
• W2146826953 countsByYear W21468269532016 @default.
• W2146826953 countsByYear W21468269532017 @default.
• W2146826953 countsByYear W21468269532018 @default.
• W2146826953 countsByYear W21468269532019 @default.
• W2146826953 countsByYear W21468269532020 @default.
• W2146826953 countsByYear W21468269532021 @default.
• W2146826953 countsByYear W21468269532022 @default.
• W2146826953 crossrefType "journal-article" @default.
• W2146826953 hasAuthorship W2146826953A5000922713 @default.
• W2146826953 hasAuthorship W2146826953A5012353323 @default.
• W2146826953 hasAuthorship W2146826953A5026167433 @default.
• W2146826953 hasAuthorship W2146826953A5030740220 @default.
• W2146826953 hasAuthorship W2146826953A5036099832 @default.
• W2146826953 hasAuthorship W2146826953A5042785839 @default.
• W2146826953 hasAuthorship W2146826953A5053797937 @default.
• W2146826953 hasAuthorship W2146826953A5055742618 @default.
• W2146826953 hasAuthorship W2146826953A5088443332 @default.
• W2146826953 hasAuthorship W2146826953A5089781644 @default.
• W2146826953 hasConcept C126322002 @default.
• W2146826953 hasConcept C134018914 @default.
• W2146826953 hasConcept C170493617 @default.
• W2146826953 hasConcept C185592680 @default.
• W2146826953 hasConcept C187345961 @default.
• W2146826953 hasConcept C2777391703 @default.
• W2146826953 hasConcept C2778110834 @default.
• W2146826953 hasConcept C2778938600 @default.
• W2146826953 hasConcept C2779306644 @default.
• W2146826953 hasConcept C2780988686 @default.
• W2146826953 hasConcept C4733338 @default.
• W2146826953 hasConcept C71924100 @default.
• W2146826953 hasConcept C86803240 @default.
• W2146826953 hasConceptScore W2146826953C126322002 @default.
• W2146826953 hasConceptScore W2146826953C134018914 @default.
• W2146826953 hasConceptScore W2146826953C170493617 @default.
• W2146826953 hasConceptScore W2146826953C185592680 @default.

• next